A UK COST-UTILITY ANALYSIS OF FERRIC CARBOXYMALTOSE VERSUS FERRIC DERISOMALTOSE IN PATIENTS WITH IRON DEFICIENCY ANEMIA AND INFLAMMATORY BOWEL DISEASE: INCORPORATION OF FRACTURE DATA

被引：0
|
作者：
Zoller, H. [1 ]
Pammer, L. M. [1 ]
Nottmeier, M. [2 ]
Poehlmann, J. [3 ]
Pollock, R. F. [3 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
[2] Pharmacosmos AS, Ballerup 84, Denmark
[3] Covalence Res Ltd, Harpenden, Herts, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE68
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [1] Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England
    Iqbal, Tariq H.
    Kennedy, Nicholas
    Dhar, Anjan
    Ahmed, Waqas
    Pollock, Richard F.
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 392 - 403
  • [2] A SWEDISH COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Lindgren, S.
    Pollock, R.
    VALUE IN HEALTH, 2023, 26 (12) : S162 - S162
  • [3] COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN TREATING IRON DEFICIENCY ANEMIA IN NORWEGIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Detlie, T. E.
    Karlsen, L. N.
    Pollock, R.
    VALUE IN HEALTH, 2023, 26 (12) : S131 - S131
  • [4] A COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH IRON DEFICIENCY ANEMIA IN CHINA
    Zhang, F.
    Shen, A.
    Ahmed, W.
    Pollock, R.
    VALUE IN HEALTH, 2023, 26 (12) : S102 - S103
  • [5] A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
    Zhang, Fengkui
    Shen, Aizong
    Ahmed, Waqas
    Pollock, Richard F.
    ADVANCES IN THERAPY, 2024, 41 (11) : 4191 - 4204
  • [6] A cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Finland
    Metsarinne, K.
    Saavuori, N.
    Ahmed, W.
    Pollock-Wilkins, R.
    Salminen, K.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1885 - I1886
  • [7] A COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN ITALY
    Cortesi, P.
    Mazzaglia, G.
    Rethmeier, L.
    Nottmeier, M.
    Pollock, R. F.
    VALUE IN HEALTH, 2022, 25 (12) : S103 - S103
  • [8] Evaluating the cost-utility of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Norway
    Detlie, T. E.
    Karlsen, L. N.
    Jorgensen, E.
    Nanu, N.
    Pollock, R. F.
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 291 - 301
  • [9] A COST-UTILITY ANALYSIS OF FERRIC DERISOMALTOSE VERSUS FERRIC CARBOXYMALTOSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE UNITED KINGDOM
    Iqbal, T. H.
    Kennedy, N. A.
    Sorensen, J.
    Nottmeier, M.
    Pollock, R. F.
    VALUE IN HEALTH, 2022, 25 (12) : S133 - S133
  • [10] A COST-UTILITY ANALYSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANEMIA IN THE NETHERLANDS: REDUCED HYPOPHOSPHATEMIA AND FRACTURE INCIDENCE WITH FERRIC DERISOMALTOSE VERSUS FERRIC
    Oron, U.
    Koek, G.
    Fijn, R.
    Pollock, R.
    VALUE IN HEALTH, 2024, 27 (12) : S116 - S116
12345